Evolent Health (EVH) Osake Kurssi
Evolent Health Kurssi
Viimeisten 13 vuoden aikana Evolent Healthn liikevaihto kasvoi 51,7 % vuodessa ja ylsi 1,88 Mrd. USD:een. Evolent Healthn nettomarginaali −28,5 % on laskenut verrattuna −4,1 %:iin muutama vuosi sitten. Evolent Healthn 12 kuukauden konsensustavoitehinta on 7,00 USD, noin yli kurssia 70,5 %. 19 analyytikosta 15 suosittaa ostoa — kokonaiskonsensus on Osta.
Evolent Health osakekurssi
Evolent Health liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Evolent Health -osakkeesta
Evolent Health Inc operates under a value-based care business model. This means that the company focuses on improving patient outcomes while reducing healthcare costs. Evolent Health works closely with healthcare providers to transition from a fee-for-service payment system to a more accountable care approach. By aligning financial incentives with patient outcomes, Evolent Health helps providers deliver better-quality care at a lower cost. This business model seeks to drive innovation and efficiency in the healthcare industry while promoting a patient-centric approach. Evolent Health Inc is committed to transforming healthcare delivery through their value-based care model.
Evolent Health Inc is primarily active in the healthcare industry.
The main competitors of Evolent Health Inc in the market include industry leaders such as Cerner Corporation, Athenahealth, Inc., and Allscripts Healthcare Solutions, Inc.
Evolent Health Inc. is a leading healthcare technology and services provider. Founded in 2011, the company revolutionizes the delivery of care by partnering with health systems and physician organizations. Evolent Health's goal is to help these organizations transition to value-based care models, enhancing patient outcomes while controlling costs. With its innovative solutions and data-driven insights, the company enables healthcare providers to improve clinical and financial performance. Evolent Health Inc. has proven expertise in population health management and offers a comprehensive suite of services, including patient engagement, analytics, and revenue cycle management, making it a trusted partner in the healthcare industry.
Evolent Health Inc has achieved several significant milestones since its inception. The company successfully completed its initial public offering (IPO) in June 2015, marking a major achievement for its growth and expansion. Evolent Health Inc has also established strategic partnerships with numerous leading healthcare providers and organizations, further enhancing its position in the market. With a focus on value-based care and population health management, the company has been recognized for its innovative solutions in improving patient outcomes and reducing healthcare costs. Evolent Health Inc continues to drive industry progress through its commitment to delivering high-quality healthcare services.
Evolent Health Inc primarily operates in the United States. With headquarters in Arlington, Virginia, the company focuses on providing healthcare solutions across the nation. Evolent Health Inc has established a strong presence in several states, delivering value-based care to health systems, health plans, and physicians. Through its innovative population health management approach, Evolent Health Inc aims to improve healthcare outcomes and enhance the overall patient experience. With its extensive network and partnerships, the company continues to positively impact the healthcare industry within the United States.
Evolent Health Inc represents values of collaboration, innovation, and patient-centric care. The company's corporate philosophy revolves around transforming the health care industry by empowering physicians, improving outcomes, and reducing costs. Evolent Health Inc places a strong emphasis on technology-driven solutions and data analytics to optimize care delivery. With a focus on value-based care models, the company aims to drive positive change in the healthcare ecosystem. Evolent Health Inc's commitment to quality, accountability, and transparency positions them as a leading player in the industry, dedicated to improving the health and well-being of individuals and communities.
Analyytikot asettavat tällä hetkellä Evolent Health-osakkeelle keskimääräisen tavoitehinnan 5,83 USD (mediaani: 7,00 USD), mikä merkitsee +42,0 % viimeisimpään hintaan verrattuna. Konsensus perustuu 19 analyytikkoarvioon.
19 analyytikkoa arvioi tällä hetkellä Evolent Health-osaketta: 15 suosittaa ostoa, 4 pitoa ja 0 myyntiä. Vuodelle 2026 analyytikot odottavat Evolent Health-yhtiöltä 2,64 Mrd. USD liikevaihtoa ja 0,17 USD osakekohtaista tulosta.
Nykyisellä valuuttakurssilla Evolent Health-osake noteerataan hintaan 3,66 EUR (4,11 USD).
Evolent Health-osake (EVH) on listattuna 4 pörssissä, muun muassa: NYSE (EVH), Frankfurt (9EH.F), München (9EH.MU), Düsseldorf (9EH.DU).
Evolent Health Inc is a leading American provider of health management and claims processing services. The company offers a comprehensive and integrated health management system tailored to the needs of healthcare organizations and their patients. Evolent Health has three business areas: health plan management, popular reference group management for hospitals and healthcare organizations, and population health solution research. The main products of Evolent Health include: 1. Health plan management: Evolent Health supports health plans in managing insurance benefits for their customers. The company offers automation applications to reduce manual administrative processes, effective approaches to cost reduction for customers, and improved quality of service delivery. 2. Reference group management for hospitals and healthcare organizations: Evolent Health offers comprehensive reference group management services to hospitals and healthcare organizations. The company supports the implementation of solutions to improve workflows and provides a particularly tailored range of services. 3. Population health solutions: Evolent Health operates in the areas of digital transformation, analytics, and workforce management, developing corresponding population health solutions. These solutions are tailored to the individual needs of individuals and groups and aim to improve health and well-being. Overall, Evolent Health uses modern technologies and advanced analytics and data management tools to create a holistic strategy for health systems and service providers. The company works closely with its clients and partner companies to develop customized solutions and implement goals in a timely and effective manner. Evolent Health emphasizes open and trusting collaboration. In summary, the business model of Evolent Health is very complex and innovative. The company specializes in efficient and cost-effective health plan administration, as well as population health solutions. Through its tailored solutions and dedicated collaboration with clients and partners, Evolent Health has established a leading role in the healthcare sector.
odotettu liikevaihto Evolent Health on 2,64 Mrd. USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto Evolent Health on 19,00 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Evolent Health:n hinta-voitto-suhde (P/E) on tällä hetkellä 24,67. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Evolent Health-osakkeen arvostusta.
Evolent Health:n hinta-myynti-suhde (P/S) on tällä hetkellä 0,18. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Evolent Health-osakkeen arvostuskennuslukuna.
Evolent Health:n Eulpool-laatuscore on 3/10.
Evolent Health:n ISIN on US30050B1017. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Evolent Health:n WKN on A14UCN. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Evolent Health:n ticker on EVH. Tämä pörssinoteeraus käytetään Evolent Health-osakkeiden kauppaan pörssissä.
Evolent Health osake
Evolent Health vertaisryhmä
Evolent Health Ticker
Evolent Health FIGI
Kaikki tunnusluvut ja syvällinen analyysi Evolent Health:sta
Meidän osakeanalyysimme Evolent Health-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Evolent Health:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: